DOXORUBICIN HYDROCHLORIDE INJECTION 50MG – Third Party Manufacturing | Medizia Biotech

DOXORUBICIN HYDROCHLORIDE INJECTION 50MG is a high-quality chemotherapy injection widely used in the treatment of various cancers, including breast cancer, ovarian cancer, lung cancer, bladder cancer, leukemia, lymphoma, and soft tissue sarcomas. Manufactured under stringent GMP-compliant quality standards, this injectable formulation ensures safety, efficacy, and consistent therapeutic performance.

Medizia Biotech is a trusted third-party manufacturer of Doxorubicin Hydrochloride Injection 50MG in India, offering reliable contract manufacturing solutions for pharmaceutical companies, hospitals, government tenders, exporters, and healthcare distributors. Our state-of-the-art manufacturing facilities follow strict quality control procedures to deliver products that meet national and international regulatory standards.

We provide comprehensive third-party manufacturing services, including custom packaging, private labeling, regulatory documentation support, and timely delivery. Whether you require small-batch manufacturing, bulk production, or ready-to-market branding, Medizia Biotech offers flexible manufacturing solutions tailored to your business needs.

Why Choose Medizia Biotech?

• GMP-compliant manufacturing facility
• Third-party & contract manufacturing services
• Private labeling and customized packaging
• Ready stock and bulk production capability
• Low MOQ and small batch manufacturing available
• Timely delivery across India and export markets
• Dedicated quality assurance and regulatory support

Partner with Medizia Biotech for dependable Doxorubicin Hydrochloride Injection 50MG third-party manufacturing and expand your oncology product portfolio with confidence. Contact us today to discuss manufacturing, bulk supply, Pharma franchise, and export opportunities.